retatrutide diabetes trial The power of three: Retatrutide's role in modern obesity and therapy Retatrutide Phase 2: Type 2
Description
Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome
A retrospective, population-based cohort study found that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was safe and associated with lower risks of cardiovascular or psychiatric comorbidities and lower mortality among patients with psoriasis
It is NOT FDA-approved and has not been reviewed by the FDA for safety, efficacy, or quality
The brain was harvested and the olfactory bulb dissected and immediately sectioned in 12 slices of 150 m using a vibratome
MORE VIDEOS IN Obesity What is a GLP-1
Hendrikse et al., 2015
